TSS
VBIO

Two Sigma Securities’s Valion Bio VBIO Stock Holding History

Two Sigma Securities’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.28K Buy
+406
New +$8.83K ﹤0.01% 1594
2024
Q4 		– Sell
-67
Closed -$7.12K – 3145
2024
Q3 		$7.12K Buy
+67
New +$10.1K ﹤0.01% 2646
2023
Q3 		– Sell
-2
Closed -$10.3K – 3476
2023
Q2 		$10.3K Buy
+2
New +$10.7K ﹤0.01% 2591
2023
Q1 		– Hold
0
– -$8.05K – 3265
2022
Q4 		– Hold
0
– – – 2395

Other funds holding VBIO

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Two Sigma Securities's VBIO Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Valion Bio (VBIO) in Q2 2026: 406 shares worth $5.28K. The stake represents ﹤0.01% of the portfolio and ranks #1594 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in VBIO as recently as Q3 2024.

Two Sigma Securities first reported a position in VBIO in Q2 2023 and has held it in 3 quarters since. The position peaked at $10.3K in Q2 2023. 11 funds tracked by Wall St. Rank hold VBIO as of Q2 2026.

  • Two Sigma Securities held 406 shares of Valion Bio worth $5.28K as of Q2 2026.
  • Valion Bio was a new Two Sigma Securities position in Q2 2026.
  • Valion Bio made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1594 holding.
  • Two Sigma Securities first reported a position in Valion Bio in Q2 2023 and has held it in 3 quarters since.
  • Two Sigma Securities's Valion Bio position peaked at $10.3K in Q2 2023.
  • 11 funds tracked by Wall St. Rank held Valion Bio as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.